You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
AstraZeneca said the "cornerstone" of the commitment would be a new weight management production facility for its oral GLP-1 drug.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.